TL;DR: The Centers for Medicare & Medicaid Services modified NCD 184 governing diagnostic pap smear coverage under Medicare Part B, with an effective date of March 7, 2026. Here's what billing teams need to know.
This update to NCD 184 Medicare clarifies the five indications that qualify a pap smear as diagnostic — not screening — and therefore billable under Medicare Part B as a diagnostic laboratory test. The policy does not list specific CPT codes. That gap creates real billing risk, and your team needs to address it now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS |
| Policy | Diagnostic Pap Smears — NCD 184 |
| Policy Code | NCD 184 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Obstetrics & Gynecology, Primary Care, Women's Health, Clinical Laboratory |
| Key Action | Audit your pap smear claims to confirm each one meets a qualifying diagnostic indication before billing under Part B |
CMS Diagnostic Pap Smear Coverage Criteria and Medical Necessity Requirements 2026
NCD 184 is the National Coverage Determination governing CMS diagnostic pap smear coverage policy under Medicare Part B. This is separate from screening pap smears — and that distinction is where most claim denials happen.
A diagnostic pap smear is covered under Part B when a physician orders it based on one of five specific conditions. All five point to a clinical reason beyond routine screening. The physician's judgment is explicitly part of the criteria.
Here are the five qualifying indications, directly from the policy:
| # | Covered Indication |
|---|---|
| 1 | Previous cancer of the cervix, uterus, or vagina that has been or is presently being treated |
| 2 | Previous abnormal pap smear |
| 3 | Any abnormal findings of the vagina, cervix, uterus, ovaries, or adnexa |
| 4 | Any significant complaint by the patient referable to the female reproductive system |
| 5 | Any signs or symptoms that the physician reasonably judges to be related to a gynecologic disorder |
The fifth indication is the broadest — and the most defensible when documented correctly. If the physician documents a clinical judgment connecting the patient's signs or symptoms to a possible gynecologic disorder, that supports medical necessity. Without that documentation, you're billing into a denial.
The real issue here is that CMS places the coverage determination squarely on physician judgment and documentation. Your billing team can't manufacture medical necessity after the fact. The order must reflect one of these five indications at the time of service.
Prior authorization is not mentioned in this policy. But the absence of a prior auth requirement doesn't reduce your documentation burden. Medical necessity still has to be established and documented in the record before you bill.
Reimbursement under this policy runs through Medicare Part B as a diagnostic laboratory test. That benefit category matters for how you route and code the claim. Diagnostic lab services have different claim processing rules than physician services, so confirm your billing pathway matches the benefit category.
CMS Diagnostic Pap Smear Exclusions and Non-Covered Indications
This policy covers diagnostic pap smears. It does not cover routine screening pap smears. That's not a gray area.
Screening pap smears have their own National Coverage Determination — NCD 210.2. CMS explicitly cross-references 210.2 in NCD 184. If a patient presents for a routine, periodic pap smear with no qualifying clinical indication, that claim belongs under 210.2, not NCD 184.
Billing a routine screening visit as diagnostic is a compliance risk, not just a claim denial risk. If your team is coding based on what pays rather than what happened clinically, that's a problem your compliance officer needs to know about before March 7, 2026.
The distinction in practice: a patient with no symptoms, no history of abnormal results, and no prior gynecologic cancer who presents for her annual exam gets a screening pap. A patient who mentions pelvic pain, has a history of cervical dysplasia, or had a prior abnormal result gets a diagnostic pap — with the physician's documentation connecting the dots.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Previous cancer of the cervix, uterus, or vagina (treated or under treatment) | Covered | Not specified in policy | Physician order required; document active or prior treatment |
| Previous abnormal pap smear | Covered | Not specified in policy | Prior result must be documented in the record |
| Abnormal findings of the vagina, cervix, uterus, ovaries, or adnexa | Covered | Not specified in policy | Clinical findings must be documented at time of order |
| Significant patient complaint referable to the female reproductive system | Covered | Not specified in policy | Document the patient's complaint verbatim and the physician's clinical reasoning |
| Signs or symptoms the physician judges related to a gynecologic disorder | Covered | Not specified in policy | Broadest indication; physician's documented judgment is the key evidence |
| Routine screening pap smear (no qualifying indication) | Not Covered under NCD 184 | See NCD 210.2 | Bill under screening benefit — do not use NCD 184 |
CMS Diagnostic Pap Smear Billing Guidelines and Action Items 2026
The effective date of March 7, 2026 is your deadline. Here's what to do before then.
| # | Action Item |
|---|---|
| 1 | Audit your existing pap smear claims from the past 12 months. Pull claims billed as diagnostic and confirm each one has a documented qualifying indication from the NCD 184 list. If you find claims without clear documentation, flag them for your compliance officer now. |
| 2 | Update your intake and documentation workflows. Physicians and clinical staff need to know these five indications. A simple reference card in the exam room or EHR template field prompting for gynecologic complaint documentation will reduce denials. |
| 3 | Separate your diagnostic and screening pap smear billing pathways. These are two different benefit categories, two different NCDs, and potentially different claim types. If your team routes all pap smears the same way, fix that before March 7, 2026. |
| 4 | Confirm your pap smear billing maps to the diagnostic laboratory benefit category. NCD 184 sits under diagnostic laboratory tests in Medicare Part B. Make sure your charge capture and claim submission reflect that benefit category correctly. |
| 5 | Review your denial patterns for pap smear claims. If you're seeing rejections on diagnostic pap smears, the root cause is almost always one of two things: missing documentation of a qualifying indication, or a screening claim incorrectly billed as diagnostic. Both are fixable with a targeted audit. |
| 6 | Talk to your compliance officer if you're unsure about how your current process maps to these five indications. The line between "significant complaint" and "routine visit" can blur in practice. If your physicians aren't consistently documenting clinical reasoning for diagnostic orders, that's a compliance exposure — not just a billing inefficiency. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Diagnostic Pap Smears Under NCD 184
The NCD 184 policy document does not list specific CPT, HCPCS, or ICD-10 codes. This is a notable gap in the published policy.
That doesn't mean you bill without codes — it means you need to identify the correct codes through other channels. The most reliable sources are your Medicare Administrative Contractor's local coverage determination (LCD) for pap smear services, the CMS fee schedule, and your MAC's billing guidelines for diagnostic laboratory tests.
Why the Missing Codes Matter for Diagnostic Pap Smear Billing
Without code-level guidance in the NCD itself, your team has to do more work to get this right. You can't rely on the national policy to tell you exactly which CPT to use for each type of pap smear collection or processing service.
Contact your MAC directly and request their LCD or billing guidelines for diagnostic pap smears under Part B. Many MACs publish companion documents to NCDs that fill in code-level detail. Pull those documents and cross-reference them with your charge master before March 7, 2026.
Do not guess at codes. Billing a code not supported by your MAC's coverage determination for this service creates claim denial risk and potential overpayment exposure.
ICD-10-CM Diagnosis Codes
No ICD-10 codes are specified in the NCD 184 policy document. Your ICD-10 selection should directly reflect the qualifying indication documented in the physician's order.
For example:
- A patient with a history of cervical cancer needs a diagnosis code that reflects that history.
- A patient with a documented complaint of abnormal vaginal discharge needs a diagnosis code for that complaint.
- A patient whose physician documented signs potentially related to a gynecologic disorder needs a diagnosis code for those specific signs or symptoms.
The ICD-10 on the claim has to match the qualifying indication that makes the service diagnostic under NCD 184. If the diagnosis code you submit looks like a routine screening code, your claim is going to get denied — regardless of what happened clinically.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.